Phio Pharmaceuticals Corp Stock Investor Sentiment
| PHIO Stock | USD 1.42 0.01 0.70% |
About 51% of Phio Pharmaceuticals' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Phio Pharmaceuticals Corp suggests that some traders are interested. Phio Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Phio Pharmaceuticals Corp. Many technical investors use Phio Pharmaceuticals Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Phio |
Phio Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Phio Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Phio Pharmaceuticals that are available to investors today. That information is available publicly through Phio media outlets and privately through word of mouth or via Phio internal channels. However, regardless of the origin, that massive amount of Phio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Phio Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Phio Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Phio Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Phio Pharmaceuticals alpha.
Phio Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Dispersyn Gerrit of 68450 shares of Phio Pharmaceuticals subject to Rule 16b-3 | 11/29/2024 |
2 | Acquisition by Caitlin Kontulis of 4500 shares of Phio Pharmaceuticals subject to Rule 16b-3 | 12/03/2024 |
3 | Phio Pharmaceuticals is a Finalist for the Technology Disruptor of the Year Award | 12/10/2024 |
4 | Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Continue to Third Dose Cohort in its Clinical Study of PH-762 | 12/19/2024 |
5 | Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology | 01/02/2025 |
6 | Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762 | 01/13/2025 |
7 | Phio Pharmaceuticals Announces 3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 01/14/2025 |
8 | Phio Pharmaceuticals Announces Closing of 1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 01/21/2025 |
9 | Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors | 02/20/2025 |
Check out Phio Pharmaceuticals Hype Analysis, Phio Pharmaceuticals Correlation and Phio Pharmaceuticals Performance. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.